BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 20138330)

  • 1. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
    Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
    Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
    Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
    Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
    Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
    Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
    Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
    Day TF; Guo X; Garrett-Beal L; Yang Y
    Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal chondrosarcoma: clinicopathologic study of 20 cases.
    Shakked RJ; Geller DS; Gorlick R; Dorfman HD
    Arch Pathol Lab Med; 2012 Jan; 136(1):61-75. PubMed ID: 22208489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
    Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts.
    Sugiki T; Uyama T; Toyoda M; Morioka H; Kume S; Miyado K; Matsumoto K; Saito H; Tsumaki N; Takahashi Y; Toyama Y; Umezawa A
    J Cell Biochem; 2007 Apr; 100(5):1240-54. PubMed ID: 17115412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system.
    Rushing EJ; Armonda RA; Ansari Q; Mena H
    Cancer; 1996 May; 77(9):1884-91. PubMed ID: 8646689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic tensile strain facilitates the ossification of ligamentum flavum through β-catenin signaling pathway: in vitro analysis.
    Cai HX; Yayama T; Uchida K; Nakajima H; Sugita D; Guerrero AR; Yoshida A; Baba H
    Spine (Phila Pa 1976); 2012 May; 37(11):E639-46. PubMed ID: 22158061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells.
    Nochi H; Sung JH; Lou J; Adkisson HD; Maloney WJ; Hruska KA
    J Bone Miner Res; 2004 Jan; 19(1):111-22. PubMed ID: 14753743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
    Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
    J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
    Chiba H; Matsuyama T
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
    Wenke AK; Grässel S; Moser M; Bosserhoff AK
    FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletogenesis in Xenopus tropicalis: characteristic bone development in an anuran amphibian.
    Miura S; Hanaoka K; Togashi S
    Bone; 2008 Nov; 43(5):901-9. PubMed ID: 18692165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
    Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
    Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfall in the diagnosis of mesenchymal chondrosarcoma arising in the central nervous system.
    Lin L; Varikatt W; Dexter M; Ng T
    Neuropathology; 2012 Feb; 32(1):82-90. PubMed ID: 21615516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
    Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
    Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.